Skip to content
GLP-1 Scorecard
Menu
Graded #109

Rex MD

Rex MD is a US-based men's-health telehealth platform (a LifeMD brand) offering a 100 percent online GLP-1 weight-management program.

Visit Rex MDWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$199/mo (brand-name)
Tirzepatide
$349/mo (brand Zepbound)
Coverage
All 50 states
Brand-name
Yes

Weigh Rex MD against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value60/100
Dose & formulation77/100
Clinical oversight84/100
Labs & monitoring53/100
Fulfillment89/100
Contract terms55/100

Strengths

  • Flat $199/mo program bundles consult, medication and overnight shipping
  • Brand-name semaglutide and Zepbound vials, not just compounded
  • Serves all 50 states, fully online
  • LegitScript certified with US-based, state-licensed providers
  • Backed by parent company LifeMD

Where it loses points

  • Does not accept insurance
  • Marketed primarily to men via a men's-health platform
  • Zepbound vial cost rises with dose titration
  • Branded-only program costs more than compounded options

Bottom line — Grade C

Best for: Shoppers who want men wanting a flat-fee, all-inclusive branded GLP-1 program nationwide.

Ranked #109 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Rex MD — the realistic shortlist.

The 21 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Rex MD's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Rex MD's site. Not medical advice; see our disclosure.

← Back to the scorecard